IP Library Granted Patent US 12,185,909
Granted Patent B2
US 12,185,909 · App. 17/029,263 · Granted Jan 7, 2025

System and method for cleansing segments of a luminal network

Inventor: William S. Krimsky (Forest Hill, MD)
Assignee: Covidien LP
A61B1/00082A61B1/00085A61B1/015A61B1/018A61B5/062A61B10/0045A61B10/02A61M13/00A61M16/0404A61M16/0459A61M16/0479A61M25/007A61M25/1011A61B6/486A61B2017/00809A61B2034/105A61B34/20A61B2034/2051A61B2034/2072A61B2090/3925A61K9/0073A61M2025/1052
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,185,909
App. No.
17/029,263
Granted
Jan 7, 2025
Kind
B2
Abstract

A method and system for instilling a medium into portions of a luminal network is provided. The method includes generating a model of a luminal network based on images of the luminal network, determining a location of a treatment target in the luminal network, navigating a bronchoscope through the bronchial tree to a target, guiding a catheter through the bronchoscope, dispensing medium to the target from a distal end of the catheter, and removing a quantity of medium from the luminal network.

Claims (52)

1. A method of instilling a therapy medium into portions of a luminal network comprising:

generating a model of a luminal network based on images of the luminal network;

determining a location of a target in the luminal network;

guiding a catheter to the target, the catheter including a medium channel and at least one medium outlet in fluid communication with the medium channel for delivering a therapy medium to the target;

isolating an area of the luminal network around the target by inflating a first balloon coupled to the catheter and inflating a second balloon coupled to the catheter distal to the first balloon such that the isolated area is disposed between the first and second inflated balloons;

passing air through a bypass channel of the catheter, the bypass channel extending distal to the isolated area and extending through the catheter distally beyond a distal end of the medium channel, wherein a distal-most end of the catheter forms a distal opening of the bypass channel through which the air exits the bypass channel for delivery into the luminal network distal to the isolated area of the luminal network;

dispensing, via the at least one medium outlet, the therapy medium within the isolated area of the luminal network to the target;

removing a volume of the therapy medium from the isolated area of the luminal network;

measuring the volume of therapy medium removed from the isolated area of the luminal network; and

determining whether the volume of the therapy medium removed from the isolated areas of the luminal network equals or exceeds a threshold volume based on a volume of the therapy medium dispensed to the isolated area of the luminal network.

2. The method of claim 1 , further comprising:

generating an electromagnetic field about the luminal network;

inserting a location sensor into the electromagnetic field;

tracking a location of the location sensor coupled to the catheter while the location sensor is navigated within the luminal network; and

displaying guidance for navigating the location sensor within the luminal network,

wherein the location sensor includes magnetic field sensors configured to sense the magnetic field and to generate position signals in response to the sensed magnetic field.

3. The method of claim 1 ,

wherein the first balloon, when inflated, prevents the therapy medium from advancing past the first balloon such that the therapy medium remains distal to the first balloon.

4. The method of claim 1 , wherein the second balloon, when inflated, prevents the therapy medium from advancing such that the medium remains proximal to the second balloon, and the first balloon and the second balloon isolate a volume of the luminal network.

5. The method of claim 1 , wherein the therapy medium is one or more of an antibacterial, an antifungal, an antiviral, an immunotherapy solution, a fluid, an aerosol, a powder, an epoxy, and a sealant.

6. The method of claim 1 , wherein the therapy medium is dispensed using a manual syringe.

7. The method of claim 1 , wherein the therapy medium is dispensed using a pump.

8. The method of claim 1 , further comprising:

measuring an internal luminal pressure; and

halting therapy medium dispensing if the internal luminal pressure exceeds a pressure value.

9. A method of instilling a therapy medium into portions of a luminal network comprising:

guiding a catheter to a target within the luminal network, the catheter including a medium channel and at least one medium outlet in fluid communication with the medium channel for delivering a therapy medium to the target;

isolating an area around the target by inflating a first balloon coupled to the catheter and inflating a second balloon coupled to the catheter distal to the first balloon such that the isolated area is disposed between the first and second inflated balloons;

passing air through a bypass channel of the catheter, the bypass channel extending distal to the isolated area and extending through the catheter distally beyond a distal end of the medium channel, wherein a distal-most end of the catheter forms a distal opening of the bypass channel through which the air exits the bypass channel for delivery into the luminal network distal to the isolated area of the luminal network;

dispensing, via the at least one medium outlet, the therapy medium within the isolated area of the luminal network to the target;

removing a volume of the therapy medium from the isolated area of the luminal network;

measuring the volume of therapy medium removed from the isolated area of the luminal network; and

determining whether the volume of the therapy medium removed from the isolated area of the luminal network equals or exceeds a threshold volume based on a volume of the therapy medium dispensed within the isolated area of the luminal network.

10. The method of claim 9 ,

wherein the first balloon, when inflated, prevents the therapy medium from advancing past the balloon such that the medium remains distal to the first balloon.

11. The method of claim 9 ,

wherein the second balloon, when inflated, prevents the therapy medium from advancing such that the medium remains proximal to the second balloon, and the first balloon and the second balloon isolate a volume of the luminal network.

12. The method of claim 9 , wherein the therapy medium is one or more of an antibacterial, an antifungal, an antiviral, an immunotherapy solution, a fluid, an aerosol, a powder, an epoxy, and a sealant.

13. The method of claim 9 , wherein the therapy medium is dispensed using a manual syringe.

14. The method of claim 9 , wherein the therapy medium is dispensed using a pump.

15. The method of claim 9 , further comprising:

measuring an internal luminal pressure; and

halting therapy medium dispensing if the internal luminal pressure exceeds a pressure value.

16. A method of instilling a therapy medium into portions of a luminal network comprising:

guiding a catheter to a target within the luminal network, the catheter including a medium channel and at least one medium outlet in fluid communication with the medium channel for delivering a therapy medium to the target;

isolating an area of the luminal network around the target by inflating a first balloon and a second balloon coupled to a distal portion of the catheter until the first balloon contacts walls of the luminal network and the second balloon contacts walls of the luminal network creating a seal between the first balloon and the second balloon;

passing air through a bypass channel of the catheter, the bypass channel extending distal to the isolated area and extending through the catheter distally beyond a distal end of the medium channel, wherein a distal-most end of the catheter forms a distal opening of the bypass channel through which the air exits the bypass channel for delivery into the luminal network distal to the isolated area;

dispensing, via the at least one medium outlet, the therapy medium within the isolated area of the luminal network to the target;

removing a volume of the therapy medium from the isolated area of the luminal network;

measuring the volume of therapy medium removed from the isolated area of the luminal network; and

determining whether the volume of the therapy medium removed from the luminal network equals or exceeds a threshold volume based on a volume of the dispensed therapy medium.

17. The method of claim 16 , wherein the therapy medium is one or more of an antibacterial, an antifungal, an antiviral, an immunotherapy solution, a fluid, an aerosol, a powder, an epoxy, and a sealant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: KRIMSKY, WILLIAM S.
To: COVIDIEN LP
Reel/Frame 053856/0777 →
Continuity (3)
Division 15700243 · Sep 11, 2017
Provisional Application 62396322 · Sep 19, 2016
Related Publication 20210000330A1 · Jan 7, 2021
References Cited (26)
US 5029580A · Radford et al. · 1991 [cited by applicant]
US 5165420A · Strickland · 1992 [cited by applicant]
US 5246012A · Strickland · 1993 [cited by applicant]
US 5411479A · Bodden · 1995 [cited by examiner]
US 5893841A · Glickman · 1999 [cited by examiner]
US 6398775B1 · Perkins et al. · 2002 [cited by applicant]
US 10799092B2 · Krimsky · 2020 [cited by applicant]
US 20030051733A1 · Kotmel · 2003 [cited by examiner]
US 20060095066A1 · Chang et al. · 2006 [cited by applicant]
US 20060184016A1 · Glossop · 2006 [cited by applicant]
US 20080114286A1 · Hamel et al. · 2008 [cited by applicant]
US 20100041949A1 · Tolkowsky · 2010 [cited by applicant]
US 20110245665A1 · Nentwick · 2011 [cited by applicant]
US 20120046521A1 · Hunter · 2012 [cited by examiner]
US 20140018732A1 · Bagaoisan et al. · 2014 [cited by applicant]
US 20140142376A1 · Ghosh · 2014 [cited by examiner]
US 20150272666A1 · Wang · 2015 [cited by examiner]
CN 104220014A · 2014 [cited by applicant]
CN 104220015A · 2014 [cited by applicant]
EP 2508221A1 · 2012 [cited by applicant]
WO WO2004080508A2 · 2004 [cited by examiner]
Office Action issued in corresponding application CN 201710847394.8 dated Oct. 9, 2021 (9 pages). [cited by applicant]
Extended European Search Report for application No. 171919327 dated Feb. 26, 2018, 9 pages. [cited by applicant]
Australian Examination Report for application No. 2017232030 dated Mar. 9, 2018, 9 pages. [cited by applicant]
Australian Office Action issued in Application No. 2017232030, dated Aug. 1, 2018. [cited by applicant]
Canadian Office Action issued in Application No. 2979117, dated Aug. 2, 2018. [cited by applicant]